Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Todd, Baughman"'
Autor:
Todd Shearer, Rex L. Williams, Mark Johnson, Ewa Cendrowicz, Cathrine Leonowens, Margaret Smith, Todd Baughman, Caroline J. Breitbach, L. Mary Smith, Michael Burgess, Shinta Cheng
Publikováno v:
Blood. 140:3080-3081
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d2e6044ee4fbe3baab1c59c05d304a2
https://doi.org/10.1182/blood-2022-156811
https://doi.org/10.1182/blood-2022-156811
Autor:
Todd Baughman, Patricia C. Ryan, Rakesh Dixit, Nicholas Buss, Denis Roy, Carolyn Gordon, Claire Patterson
Publikováno v:
Journal of Applied Toxicology. 38:1293-1301
Exenatide, a glucagon-like peptide-1 receptor agonist was originally developed as either a twice daily or once weekly injectable therapeutic for patients with type 2 diabetes. Exenatide QW suspension was developed for use with an autoinjector device,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4def94556c6dccbd63e1a8fedb2fa573
https://doi.org/10.1002/jat.3640
https://doi.org/10.1002/jat.3640
Autor:
Nicholas, Buss, Patricia, Ryan, Todd, Baughman, Denis, Roy, Claire, Patterson, Carolyn, Gordon, Rakesh, Dixit
Publikováno v:
Journal of applied toxicology : JAT. 38(10)
Exenatide, a glucagon-like peptide-1 receptor agonist was originally developed as either a twice daily or once weekly injectable therapeutic for patients with type 2 diabetes. Exenatide QW suspension was developed for use with an autoinjector device,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::01e44f91a1fb001b07669d32b50b538b
https://pubmed.ncbi.nlm.nih.gov/29806696
https://pubmed.ncbi.nlm.nih.gov/29806696